Alain Fournier

General Motors Corporation in its joint venture with Lithium Americas Corp.

On October 16, 2024, General Motors Corporation announced its joint venture with Lithium Americas Corp. for the purposes of developing the Thacker Pass project whereby GM is investing US$625 million for a 38% asset level ownership interest in Thacker Pass. As part of the transaction, GM has also...

Lead Office: Vancouver Date Announced: Oct 16, 2024 Value: US$625 million

BDC Capital in connection with Cyclic Material’s $71-million Series B financing round

On September 25, 2024, Cyclic Materials announced it raising of $71 million of Series B financing. This all-equity, all-primary financing round was led by ArcTern Ventures and included BDC Capital’s Climate Tech Fund, Hitachi Ventures, Zero Infinity Partners, Climate Investment, Microsoft...

Lead Office: Montreal Date Announced: Sep 25, 2024 Value: $71 million

Difenda in its acquisition by Quorum Cyber

On September 13, 2024, Quorum Cyber announced its acquisition of Difenda. Collectively the companies will strengthen their leadership position as a leader of Microsoft Security services and accelerate its global expansion and scale meaningfully into new regions. Difenda is a Microsoft Security...

Lead Office: Toronto Date Announced: Sep 13, 2024 Value: --

Amplitude Ventures in its closing of its $263 million venture capital fund

On May 28, 2024, Amplitude Ventures announced it closed $263 million in its second venture capital fund for precision medicine. Through this fund, the company plans to continue investing in new precision medicine companies with an interest in biology and artificial intelligence. This fund is...

Lead Office: Montreal Date Announced: May 28, 2024 Value: $263 million

Mapei in its acquisition of Diaplas

On February 2, 2024, Mapei, through its subsidiary Mapei Canada, announced its acquisition of Diaplas. The acquisition will afford Mapei new opportunities to expand within North America and diversify their current product offerings. Mapei S.p.A. is an Italy-based manufacturer of chemical...

Lead Office: Montreal Date Closed: February 2, 2024 Value: -

Powerside in its securing of strategic growth funding from Energy Growth Momentum LP.

On December 12, 2023, Powerside dba (Power Survey and Equipment Ltd.). announced its securing strategic growth funding from Energy Growth Momentum LP. This funding will be used for power quality product platform and expansion. Powerside offers innovative solutions for power intelligence...

Lead Office: Montreal Date Announced: Dec 12, 2023 Value: --

Luge Capital in its closing of $71 million of its target $100 million fund

On September 26, 2023, Luge Capital Inc. announced that it closed $71 million of its target $100 million fund. The Limited Partners in the new fund, Luge Capital Fund II, consisted of existing investors including Caisse de dépôt et placement du Québec (CDPQ), Desjardins, BDC Capital, Sun...

Lead Office: Toronto Date Closed: September 26, 2023 Value: $71 million

Inversago Pharma in its US$1.075 billion business combination with Novo Nordisk

On August 10, 2023, Inversago Pharma announced its business combination with Nova Nordisk for US$1.075 billion pursuant to the completion of certain development and commercial milestones. This acquisition will strengthen Nova Nordisk’s clinical development and research capability for obesity and...

Lead Office: Montreal Date Closed: -- Value: US$1.075 billion

Photonis Group in its agreement to acquire Telops

On April 11, 2023, Photonis announced that it entered into an agreement to acquire Telops. Through this acquisition, Photonis plans to expand their technical expertise with the addition of hyperspectral capabilities to their portfolio. The combined business will offer unique high-end imaging...

Lead Office: Montreal Date Closed: -- Value: -

Nichi-Iko Pharmaceutical Co. in its US$ 100 million sale to Ellimist Singapore Pte. Ltd.

On February 28, 2023, Nichi-Iko Pharmaceutical Co., Ltd. sold all issued and outstanding shares of its wholly owned subsidiaries, Sagent Pharmaceuticals, based in Wyoming, and Omega Laboratories Ltd., based in Montreal, to Ellimist Singapore Pte. Ltd. for an aggregate purchase price of...

Lead Office: Montreal Date Closed: February 28, 2023 Value: $100 million